Key result
Structured follow-up consultations modestly increase 6-month patient activation scores by ~1 point.
Why the study?
The cost-effectiveness of the two modular components of the DECADE intervention—structured patient-centered follow-up consultations and patient materials for tailored use—for CVD prevention in German primary care needed to be evaluated.
Does a modular self-management intervention comprising structured follow-up consultations and tailored patient materials cost-effectively improve patient activation (PAM13) and 10-year cardiovascular risk in primary care patients with lifestyle-related cardiovascular risk factors?
RCT (n=712)
2x2 factorial cluster randomization (1:1:1:1 at the general practice level)
Yes
Does a modular self-management intervention comprising structured follow-up consultations and tailored patient materials cost-effectively improve patient activation (PAM13) and 10-year cardiovascular risk in primary care patients with lifestyle-related cardiovascular risk factors?
Answers are grounded in this paper and cite their sources.
In German primary care, structured follow-up consultations modestly increased patient activation at 6 months for €89.48 per PAM13 point gained without improving 10-year cardiovascular risk, whereas low-cost patient materials did not improve patient activation and showed a statistically uncertain stabilization of 10-year cardiovascular risk.
Background To evaluate the cost-effectiveness of two modular components of the DECADE intervention, structured patient-centered follow-up consultations (‘Consultations’) and patient materials for tailored use (‘Materials’), for cardiovascular disease (CVD) prevention in German primary care. Methods The health economic evaluation was conducted alongside a 2 × 2 factorial cluster-randomized trial in German general practices. Patients aged 30–75 years with at least one lifestyle-related CVD risk factor were included. The cost-effectiveness of ‘Consultations’ was assessed by comparing groups that received structured follow-up consultations with those that did not. The cost-effectiveness of ‘Materials’ was assessed by comparing groups that received patient materials with those that did not. Incremental costs were combined with effects on the patient-reported Patient Activation Measure (PAM13) and the calculated 10-year cardiovascular risk (CVR) score. Incremental Cost-Effectiveness Ratios (ICERs) were calculated, and statistical uncertainty was assessed using non-parametric bootstrapping and cost-effectiveness acceptability curves. Results The ‘Consultations’ intervention showed a slight, significant improvement in the PAM13 score at 6 months of 1.14 points (95% CI 0.09 to 2.19, p = 0.033). The corresponding ICER was €89.48 (95% CI €46.42 to €1,105.30) per one-point PAM13 improvement. The ‘Consultations’ intervention did not affect the CVR score ( p = 0.72). The ‘Materials’ intervention was associated with a noninformative result regarding the PAM13 score ( p = 0.57), but was associated with a difference of − 1.63% points in the 10-year cardiovascular risk score relative to no materials, which was not statistically significant (95% CI − 3.28 to 0.02, p = 0.053). This difference reflects a stable risk score in the arms using materials (IG1 + 0.09, IG3 − 0.17) against a rising score in the arms without them (control group + 1.16, IG2 + 2.01) rather than an absolute reduction in risk. Based on an incremental cost of €15.03, the resulting ratio was €9.23 per percentage point of 10-year cardiovascular risk avoided (not statistically significant). Conclusions Structured, patient-centered follow-up consultations slightly increased patient activation at moderate additional cost; as no willingness-to-pay threshold exists for this outcome, cost-effectiveness cannot be established. The low-cost patient materials did not improve patient activation; the calculated 10-year cardiovascular risk remained stable in the arms using them while it rose in the arms without them, but this difference is statistically uncertain. The modular design allows flexible implementation, and further evaluation with long-term and preference-based outcomes is needed.
No takes yet. Share an insight, caveat, or question.
Kaier et al. (2026) conducted an RCT in Cardiovascular disease prevention in patients with at least one lifestyle-related CVD risk factor (n=712). DECADE structured patient-centered follow-up consultations ('Consultations') and/or tailored patient materials ('Materials') vs. No structured follow-up consultations (treatment as usual or materials only) and/or no patient materials (treatment as usual or consultations only), with baseline and 12-month arriba CVR calculations in all arms was evaluated on Change in Patient Activation Measure (PAM13, scale 0-100) score at 6 months (for Consultations vs No Consultations) (MD 1.14, 95% CI 0.09 to 2.19, p=0.033). Structured follow-up consultations increased the PAM13 score by 1.14 points at 6 months with an ICER of €89.48 per point.
Synapse has enriched 10 related papers. Consider them for comparative context: